Analysis of anti-ulcerative drug use in patients undergoing thyroid operation during perioperative period

ZHANG Qiang; LI Jian; PENG Ran; LI Yongxian

doi:10.3969/j.issn.1006-0111.2016.03.020

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To investigate anti-ulcerative drug (AUD) utility in patients undergoing thyroid operation against stress ulcer (SU) during perioperative period. Methods A total of 393 patients undergoing arthroscopic operation during Jan. to Dec. 2013 in our hospital were recruited and retrospectively analyzed with Excel spreadsheet. Results Among 393 patients in the study, eighty-five patients (21.6%) used AUD (92.9%)after operation, most (94.9%) were administered by intravenous, and drug utilization index(DUI) was 1.48. Eighty-seven point one patients used proton pump inhibitors (PPIs) in which lansoprazole was prescribed most. Conclusion PPIs were overused in patients undergoing thyroid operation.

Analysis of anti-ulcerative drug use in patients undergoing thyroid operation during perioperative period

1. Guangzhou General Hospital of Guangzhou Military Command/Guangzhou Key Laboratory of Rational Drug Use for the Elderly with Chronic Disease, Guangzhou 510010, China

2. Guangdong Pharmaceutical University, Guangzhou 510006, China

Received Date: 2015-04-10

Rev Recd Date: 2015-11-02

Key words:

thyroid operation /
AUD /
SU /
DUI

Abstract: Objective To investigate anti-ulcerative drug (AUD) utility in patients undergoing thyroid operation against stress ulcer (SU) during perioperative period. Methods A total of 393 patients undergoing arthroscopic operation during Jan. to Dec. 2013 in our hospital were recruited and retrospectively analyzed with Excel spreadsheet. Results Among 393 patients in the study, eighty-five patients (21.6%) used AUD (92.9%)after operation, most (94.9%) were administered by intravenous, and drug utilization index(DUI) was 1.48. Eighty-seven point one patients used proton pump inhibitors (PPIs) in which lansoprazole was prescribed most. Conclusion PPIs were overused in patients undergoing thyroid operation.

HTML

Reference (16)

[1]	中华医学杂志编辑委员会.应激性溃疡防治建议[J].中华医学杂志,2002,82(14):1000-1001.
[2]	ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis.ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998[J].Am J Health Syst Pharm,1999,56(4):347-379.
[3]	Bardou M, Barkun AN. Stress Ulcer Prophylaxis in the ICU:Who, When and How[J]. Crit Care Med,2013,41(3):906-907.
[4]	郭宁.外科治疗在甲状腺疾病中的应用研究[J].中国当代医学,2013,20(5):18-19.
[5]	Bez C, Perrottet N, Zingg T,et al. Stress ulcer prophylaxis in non-critically ill patients:a prospective evaluation of current practice in a general surgery department[J].J Eval Clin Pract,2013,19(2):374-378.
[6]	Heidelbaugh JJ, Inadomi JM.Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients[J].Am J Gastroenterol,2006,101(10):2200-2205.
[7]	王辉.276例外科手术使用PPIs预防应激性溃疡的用药分析[J]. 海峡药学, 2014,26(4):97-99.
[8]	Barkun A, Bardou M,Marshall JK.Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding[J]. Ann Intern Med, 2003,139:843-857.
[9]	李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639.
[10]	Barletta JF. Does histamine-2-receptor-antagonist administration lead to more gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock?[J].Ann Pharmacother, 2014,48(10):1276-1281.
[11]	Barletta JF, Sclar DA. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis:clinical and economic consequences[J].Pharmacoeconomics,2014,32(1):5-13.
[12]	熊碧芳,刘小红,戴水田,等. 泰胃美针剂对烧伤病人细胞免疫的调节作用[J]. 中国现代医学杂志,1999,9(8):24-25.
[13]	陈继民,彭淑清. 雷尼替丁与腹部手术后细胞免疫功能的关系[J]. 中华实验外科杂志,1996,13(5):277.
[14]	晓峰,姚健凤,顾同进,等. 奥美拉唑不同途径、剂量给药抑制胃酸效果[J]. 中国新药与临床杂志,2001,20(4):302-303.
[15]	黄艳兰. 应激性溃疡危险因素预防循证指南[J]. 中国煤炭工业医学杂志, 2009,12(11):1825-1826.
[16]	金仙妹,王海燕,兰美娟,等. 危重病患者早期肠内营养预防应激性溃疡的观察与护理[J]. 中华护理杂志,2002,37(7):485-487.

Message Board

Analysis of anti-ulcerative drug use in patients undergoing thyroid operation during perioperative period

doi: 10.3969/j.issn.1006-0111.2016.03.020

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views